US Broker Ratings

McKesson Corporation (MCK) Stock Analysis: Healthcare Giant with an 8.65% Upside Potential

McKesson Corporation (NYSE: MCK) stands as a towering figure in the healthcare sector, with its operations spanning across the U.S. and international markets. With a market cap of approximately $94.97..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a Potential 34% Upside in the Animal Health Sector

Investors keen on the healthcare sector, particularly in animal health, would do well to cast a discerning eye on Zoetis Inc. (NYSE: ZTS). With a market capitalization of $62.54 billion,..

Takeda Pharmaceutical (TAK): Investor Outlook with a Promising 30% Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a prominent player in the healthcare sector, stands out with its robust global footprint and expansive portfolio in drug manufacturing. With a market capitalization..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 12.6% Upside Potential

Universal Health Services, Inc. (NYSE: UHS), a titan in the healthcare sector, commands attention with its robust operations in the medical care facilities industry. Headquartered in King of Prussia, Pennsylvania,..

The Cooper Companies, Inc. (COO): Investor Outlook Highlights 21.67% Potential Upside

The Cooper Companies, Inc. (COO), a prominent player in the healthcare sector, is capturing investor attention with a potential upside of 21.67%. This figure, derived from its average target price..

IDEXX Laboratories, Inc. (IDXX): Investor Outlook on Strong Revenue Growth and a 13.15% Potential Upside

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, operates at the intersection of diagnostics and research with a market capitalization of $49.29 billion. As a leader..

Waters Corporation (WAT) Investor Outlook: Exploring a 6% Upside with Robust Revenue Growth

Waters Corporation (WAT), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, has been capturing the attention of investors with its innovative solutions and consistent..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 17% Potential Upside Amidst Robust Neurological Portfolio

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, is making waves with its extensive portfolio of therapies targeting neurological and neurodegenerative diseases. With a market capitalization of..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Navigating a Promising 18% Upside in the Biotech Leader

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable name in the biotechnology sector, boasting a substantial market capitalization of $104.55 billion. As a leader in therapies for cystic fibrosis..

Boston Scientific Corporation (BSX): Investor Outlook Shows 30.9% Upside Potential with Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX) stands as a formidable presence in the healthcare sector, particularly within the medical devices industry. With a robust market capitalization of $141.37 billion, the company..

Danaher Corporation (DHR) Stock Analysis: Exploring a Potential 20% Upside Amidst Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a stalwart in the healthcare sector, stands as a compelling investment opportunity with a market capitalization of $144.97 billion. Specializing in the diagnostics and research industry,..

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with a 7.96% Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor attention with its impressive market cap of $230.73 billion. As a leading player in the medical..

The Cigna Group (CI) Stock Analysis: Exploring a 21.49% Upside Potential for Investors

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector with a robust market cap of $80.27 billion, presents a compelling opportunity for investors seeking exposure to the healthcare..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Evaluating a Potential 11% Upside in the Healthcare Sector

IQVIA Holdings, Inc. (IQV) is making waves in the healthcare sector, standing out with a robust market capitalization of $33.69 billion. As a prominent name in the Diagnostics & Research..

Sanofi (SNY) Stock Analysis: Potential Upside and Strong Dividend Yield Attract Investor Interest

Sanofi (SNY), a leading player in the global healthcare sector, presents a compelling case for investors looking to capitalize on both stable dividend income and significant growth potential. With a..

HCA Healthcare, Inc. (HCA) Stock Analysis: Strong Revenue Growth Amid Sector Challenges

HCA Healthcare, Inc. (NYSE: HCA), a titan in the healthcare sector, operates a vast network of medical care facilities across the United States. With a market capitalization of $97.14 billion,..

Merck & Company, Inc. (MRK) Stock Analysis: Navigating a 17.92% Potential Upside in the Healthcare Sector

Merck & Company, Inc. (NYSE: MRK) stands as a towering presence in the healthcare sector, particularly within the drug manufacturing industry. With a substantial market capitalization of $214.78 billion, this..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating the Resilience and Growth Potential Amidst Market Dynamics

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust market position and diverse product portfolio. As one of..

Eli Lilly and Company (LLY) Stock Analysis: Exploring Growth and Valuation Potential in Healthcare

Eli Lilly and Company (NYSE: LLY) stands as a titan in the healthcare sector, renowned for its innovative contributions to pharmaceuticals. With a market capitalization of $747.19 billion, Eli Lilly..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Navigating a 34.30% Potential Upside in Healthcare Innovation

Intuitive Surgical, Inc. (NASDAQ: ISRG), a front-runner in the healthcare sector, continues to capture investor interest with its cutting-edge medical instruments and supplies. With a market capitalization of $154 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds